# Neubond

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neubond

- Industry: Medical Devices & Equipment
- Headquarters: London, UK
- Website: www.neubond.co.uk
- Total disclosed funding: $2.1M
- Latest round: Seed (Jun 9, 2026)
- Investors on record: 3

## About

Neubond Ltd, based in the UK, specializes in innovative neuro-rehabilitation solutions, leveraging advanced technology to assist patients in regaining independence following neurological impairments.

Founded in 2024 in London, UK, Neubond Ltd focuses on providing neuro-rehabilitation solutions. The company raised GBP 1.5 million in Seed funding on June 24, 2026, led by WASEDA University Ventures, with participation from SFC Capital and New Wave Ventures, totaling GBP 1.5 million raised to date.

Neubond specializes in innovative neuro-rehabilitation solutions that leverage advanced technology and patient-centered design. The core product integrates therapeutic exercises into daily activities, aimed at helping patients regain control and independence following neurological impairments. These solutions are accessible and empower individuals recovering from strokes, traumatic brain injuries, and other neurological conditions, with a commitment to scientific rigor through technology developed from research at Imperial College London. Neubond's products target a global market, focusing on regions with established healthcare systems and rehabilitation facilities.

Neubond is developing wearable neurorehabilitation technology and a digital rehabilitation platform for stroke recovery. The company is expected to generate revenue through commercialization of its rehabilitation device and platform for patients, healthcare providers, rehabilitation centers, and clinical organizations following regulatory approvals and market deployment.

Neubond plans to use the seed funding to complete development of its stroke rehabilitation platform and wearable neuromuscular interface, undertake a pivotal clinical study, support future clinical trials, advance regulatory approval activities, and prepare its technology for broader clinical adoption. The company aims to further validate its neurorehabilitation platform and expand access to innovative stroke recovery solutions for patients and healthcare providers.

## Funding rounds

- Seed, Jun 9, 2026, $2.1M — New Wave Ventures, SFC Capital, WASEDA University Ventures

## Investors

- New Wave Ventures (https://capitalatlas.ai/funds/new-wave-ventures) — Seed
- SFC Capital (https://capitalatlas.ai/funds/sfc-capital) — Seed
- WASEDA University Ventures (https://capitalatlas.ai/funds/waseda-university-ventures) — Seed